Medical scientists from several different universities and hospitals in China continue in the fight against cancer, along with working to create better and more comfortable treatment plans for patients in the early stages of prostate cancer. With their findings outlined in the recently published ‘Expert consensus on computed tomography-assisted three-dimensional-printed coplanar template guidance for interstitial permanent radioactive 125I seed implantation therapy,’ the research team outlines the need for better procedures in workflow.
With interstitial permanent radioactive seed implantation, cancer patients can receive large, localized doses for treating tumors. The doses affect the tumors but very little of the surrounding healthy tissue. Today, most seeds are implanted in the patient with the assistance of ultrasound guidance or computed tomography.
This type of procedure is meant to be ‘minimally invasive’ and patients are expected to have a very short recovery period after implantation of the seeds; however, CT-guided ‘puncturing’ procedures for seed implantation is ‘very complicated and time-consuming,’ state the authors, and technicians must be well-trained over a long period of time:
“At present, seed implantation brachytherapy in China is a restricted technology, which requires strict training to obtain a license. The relevant state administrative departments carry out supervision. In 2009, the Ministry of Health released the Technical Management Standards for Radioactive Seed Implantation Brachytherapy for the first time. In 2017, the National Health and Family Planning Commission released the Technical Management Standards for Radioactive Seed Implantation Brachytherapy (2017 edition), further amending and standardizing the institutional, personnel, and technical conditions and requirements for carrying out seed implantation,” reported the researchers.
“It was emphasized that physicians should receive systematic training for at least 3 months, participate in seed implantation therapy for at least 30 cases under the guidance of superior physicians, and participate in the entire management process of patients, including preoperative diagnosis, preoperative planning, implantation modality, postoperative dose verification, perioperative management, and follow-up. Only after passing the examination could they go on duty.”
Radioactive seed implantation is recommended by a wide variety of organizations related to cancer research around the world, to include:
- The American Cancer Society
- The Urology Society
- The Clinical Oncology Society
- The Radiation Oncology Society
- The Brachytherapy Society
“Seed implantation techniques for prostate carcinomas are well-established and quality assurance is controlled by transperineal ultrasound-guidance combined with planar template assistance to achieve a precise three-dimensional (3D) distribution of seeds in the prostate and ensuring seed implantation treatment is strictly followed up as per preplanning,” state the researchers.
The authors were motivated to perform this particular research because while there are templates for transrectal implantation, so far there has been no established workflow to implant seeds anywhere else in the human body—meaning that surgical pre-planning can be much more challenging, especially due to issues like movement of organs, patient’s changing position, and even interference from bone. In using 3D-PCT-guided seed implantation, assisted by CT processes, implantation is ‘suitable’ for salvage treatment of recurrent and metastatic solid tumors.
Standard workflows for CT-assisted 3D-PCT-guided seed implantation include:
- Patient position fixation
- CT-simulated positioning
- Pre-planning design
- 3D-PCT image production
- Stabilization by 3D-PCT
- Needle puncture for seed implantation
- Implantation of 125I seeds
- Post-plan evaluation
“The key to successful seed implantation is strict quality assurance in all steps,” concluded the researchers.
“Despite current data supporting 125I seed implantation for some solid carcinomas, there is a need for prospectively-randomized multicenter clinical trials to gather strong evidence for using 125I seed implantation in other solid carcinomas.”
3D printing continues to be connected with cancer treatments, from the combination of technologies like robotic surgery and 3D printing, to 3D printed phantoms for better cancer treatment, the creation of microfluidic devices, and more.
What do you think of this news? Let us know your thoughts; join the discussion of this and other 3D printing topics at 3DPrintBoard.com.
[Source / Images: ‘Expert consensus on computed tomography-assisted three-dimensional-printed coplanar template guidance for interstitial permanent radioactive 125I seed implantation therapy’]
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
3D Printing News Unpeeled: Dior, Botter and Rains 3D Print Shoes at Paris Fashion Week
Danish brand Rains has made a 3D printed TPU shoe together with Zellerfeld. Zellerfeld is a shoe 3D Printing service. Meanwhile Dior made a powder bed fusion cellular shoe out...
Digitalization and Additive Manufacturing: Leveraging the Real and Digital Worlds
Additive Manufacturing, or industrial 3D printing, has evolved from prototyping with basic materials and equipment to producing low tolerance components with limited use to additive manufacturing as we know it...
US Navy Installs Meltio Hybrid Metal 3D Printer to Reduce Repair Times
In 2022, the USS Essex became the first American Navy warship to install a metal 3D printer to ensure onboard repair capabilities of much-needed tools and parts. Now, the USS...
America Makes Announces the Winners for its 2022 Project Calls
America Makes, a U.S. National Additive Manufacturing Innovation Institute, recently announced the winners of the 2022 Rapid Innovation Call (RIC) and the Steel (HY-80) Wire-Arc Additive Heat Treatment (SWAAHT) project...